Short biography of Patrick Boisseau

Patrick Boisseau - Coordinator of the Nano2life European project – Specialist in Biotechnology-CEA

Nanoscience: Nanobiotechnology and Nanobiology

$329.00
  • Review
  • TAG : Patrick Boisseau (Author of Nanoscience) - Goodreads
ADD TO CART
  • Mr. Patrick BOISSEAU is a graduate of the Institut National Agronomique (1983) and of the Ecole Nationale du Génie Rural, des Eaux et des Forêts (1985). He holds an MSc Degree in Human Nutrition. His general academic background is therefore in biology engineering.

    To date, about 40 nanomedicines have been approved by the U.S. Food and Drug Administration and about 20 by the European Medicines Agency, says Patrick Boisseau, nanomedicine program manager at the French Atomic Energy Commission and chairman of European Technology Platform on Nanomedicine. A further 130 nanomedicines are in clinical trials. It can take more than a decade for a drug, including nanomedicines, to receive regulatory approval.

  • Patrick Boisseau coordinates and/or participates to numerous French and European funded research projects in nanobiotech and nanomedicine.

    Patrick Boisseau serves as expert or reviewer for several national/European bodies: European Commission, European Science Foundation, the European Commission, Oesterreichische Forschungsfoerderungsgesellschaft GmbH (AT), Agence Nationale de la Recherche (FR), EuroNanoMed (EU), CIBER-BBN (ES)…

    1. LIVING (RIN: 10537)
    2. Nancy Carter BOISSEAU (RIN: 10538), b. 11 November 1836
    3. Susan Elizabeth BOISSEAU (RIN: 10539), b. 31 May 1839
    4. LIVING (RIN: 10540)
    5. LIVING (RIN: 10541)
    6. Patrick BOISSEAU (RIN: 10542)

  • Name Title and Company Location Updated
    Patrick Boisseau Chairman
      12/17/15
    Rick Boisseau
      2/10/15

    Patrick Boisseau is graduated in biological engineering from the French Elite Schools Institut National Agronomique (1983) and Ecole Nationale du Génie Rural, des Eaux et des Forêts (1985). His career is fully dedicated to academic research, research and development and research management. He entered in 1987 at CEA, a French public research organisation where he occupied several functions in biological research and later in medical technologies.

Patrick Boisseau hasn't shared anything on this page with you.

Patrick Boisseau is the principal investigator of the EU-NCL, as well as the president of the European Technology Platform for Nanomedicine, and the leader of the Nanomedicine Programme at CEA Leti in France. Boisseau says that he and his colleagues are interested in “candidate nanomedicines” – nano-formulations with therapeutic and commercial potential.